Namir Hassan

Namir Hassan

Company: Zelluna Immunotherapy AS

Job title: CEO


TCR-NK: A Novel Treatment Paradigm for the Treatment of Solid Cancer 12:30 pm

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.